Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2011-04-26
2011-04-26
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S549000, C552S551000, C552S552000
Reexamination Certificate
active
07932243
ABSTRACT:
The present disclosure relates to methods and compositions to offset, ameliorate and/or alleviate one or more unwanted and/or adverse gastrointestinal effects. For example, in some embodiments, the present disclosure relates to compositions that include a bile acid, a carbohydrate and/or a pharmaceutical compound, wherein the pharmaceutical is associated with an adverse gastrointestinal effect in a subject (e.g., mammal or human). Non-limiting examples of pharmaceutical compounds may include a nonsteroidal anti-inflammatory drug, a gastric irritating drug (e.g., an antibiotic, an adrenal cortocoid steroid and an anti-cancer drug) and combinations thereof. The disclosure further relates to methods of ameliorating or eliminating at least one adverse gastrointestinal effects of a composition, comprising administering to a subject an aqueous solution comprising a bile acid and a carbohydrate.
REFERENCES:
patent: 3845770 (1974-11-01), Theeeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4036954 (1977-07-01), Murakami et al.
patent: 4092428 (1978-05-01), Murakami et al.
patent: 4113882 (1978-09-01), Okazaki et al.
patent: 4320146 (1982-03-01), Walser
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4585790 (1986-04-01), Padfield et al.
patent: 4681876 (1987-07-01), Marples et al.
patent: 4879303 (1989-11-01), Davison et al.
patent: 5057321 (1991-10-01), Edgren et al.
patent: 5149537 (1992-09-01), Azria et al.
patent: 5157022 (1992-10-01), Barbul
patent: 5260074 (1993-11-01), Sipos
patent: 5292534 (1994-03-01), Valentine et al.
patent: 5300300 (1994-04-01), Egidio et al.
patent: 5302398 (1994-04-01), Egidio et al.
patent: 5302400 (1994-04-01), Sipos
patent: 5310560 (1994-05-01), Widauer
patent: 5324514 (1994-06-01), Sipos
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5380533 (1995-01-01), Egidio et al.
patent: 5446026 (1995-08-01), Ruff et al.
patent: 5470581 (1995-11-01), Grillo et al.
patent: 5484776 (1996-01-01), Racz et al.
patent: 5516523 (1996-05-01), Heiber et al.
patent: 5534505 (1996-07-01), Widauer
patent: 5578304 (1996-11-01), Sipos
patent: 5599926 (1997-02-01), Still et al.
patent: 5641767 (1997-06-01), Wess et al.
patent: 5653987 (1997-08-01), Modi et al.
patent: 5686588 (1997-11-01), Yoo
patent: 5750104 (1998-05-01), Sipos
patent: 5750707 (1998-05-01), Spargo
patent: 5843929 (1998-12-01), Larson et al.
patent: 5846964 (1998-12-01), Ozeki
patent: 5858998 (1999-01-01), Leuschner
patent: 5863550 (1999-01-01), Maeda et al.
patent: 5898028 (1999-04-01), Jensen et al.
patent: 5945411 (1999-08-01), Larson et al.
patent: 5965164 (1999-10-01), Fuisz et al.
patent: 5977070 (1999-11-01), Piazza et al.
patent: 6099859 (2000-08-01), Cheng et al.
patent: 6210699 (2001-04-01), Acharya et al.
patent: 6245753 (2001-06-01), Byun et al.
patent: 6251428 (2001-06-01), Yoo
patent: 6309663 (2001-10-01), Patel et al.
patent: 6383471 (2002-05-01), Chen et al.
patent: 6635628 (2003-10-01), Bouscarel et al.
patent: 7034006 (2006-04-01), Yedgar et al.
patent: 7166299 (2007-01-01), Yoo
patent: 7303768 (2007-12-01), Yoo
patent: 2001/0046521 (2001-11-01), Zasloff et al.
patent: 2002/0031558 (2002-03-01), Yoo
patent: 2002/0081361 (2002-06-01), Towb et al.
patent: 2003/0044413 (2003-03-01), Steer et al.
patent: 2003/0186933 (2003-10-01), Yoo
patent: 2005/0158408 (2005-07-01), Yoo
patent: 2006/0051319 (2006-03-01), Yoo
patent: 2006/0089331 (2006-04-01), Yoo
patent: 2006/0142241 (2006-06-01), Yoo
patent: 2006/0188530 (2006-08-01), Yoo
patent: 2007/0072828 (2007-03-01), Yoo
patent: 37358/99 (1999-12-01), None
patent: 1450914 (2003-10-01), None
patent: 0086705 (1983-02-01), None
patent: 0312052 (1988-10-01), None
patent: 0 599 282 (1994-06-01), None
patent: 1255566 (2002-11-01), None
patent: 2710267 (1995-03-01), None
patent: 55 022616 (1980-02-01), None
patent: 61171421 (1986-02-01), None
patent: 62153220 (1987-07-01), None
patent: 63104925 (1988-05-01), None
patent: 63243031 (1988-10-01), None
patent: 6024991 (1994-02-01), None
patent: WO 99/61481 (1999-12-01), None
patent: 0004875 (2000-02-01), None
patent: WO 01/56547 (2001-08-01), None
patent: WO 2004/012686 (2004-02-01), None
patent: WO 2004/043342 (2004-05-01), None
patent: 2004/096123 (2004-11-01), None
patent: WO 2006/026555 (2006-03-01), None
patent: 2006/050165 (2006-05-01), None
patent: WO 2006/057637 (2006-06-01), None
Remington: The science and Practice of Pharmacy, published 2000 by Lippincott Williams and Wilkins, p. 218.
2006 Chemical Abstracts catalog, published 2006 by Chemical Abstracts Service, p. 52.
Merriam-Webster's Collegiate Dictionary, Tenth Edition, published 1998 by Merriam-Webster, Incorporated, p. 924.
Notification Concerning Transmittal of International Preliminary Report on Patentability; PCT/US2006/008925; pp. 6, Apr. 16, 2008.
“Dacarbazine”, Aidsmap Treatment and Care, http://www.aidsmap.com/en/docs/9685F4D7-D57C-4F10-A41F-D5EDF7811B3A.asp , pp. 1, Feb. 6, 2006.
“Drug Information: Dacarbazine”, Medline Plus, http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682750.html , pp. 2, Apr. 1, 2003.
“Dacarbazine”, NCI Terminology Browser, http:/
citerms.nci.nih.gov/NCIBrowser/PrintableReport.jsp?dictionary=NCI—Thesaurus&code=C411 , pp. 3, Nov. 2005.
P.J. Neveu, “The Effects of Thiol Moiety of Levamisole on Both Cellular and Humoral Immunity During the Early Response to a Hapten-Carrier Complex” Clin. Exp. Immunol. vol. 32, pp. 419-422, 1978.
E. Nagy et al., “Imuthiol Inhibits the Etoposide-Induced Apoptosis in HL-60 Cells” Immunology Letters vol. 64, pp. 1-4, 1998.
“An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients”, ClinicalTrials.gov, http://www.clinicaltrials.gov/ct/show/NCT00000650;jsessionid=AF8903A542A345FA86641E2A559AC8C9?order=1, pp. 6, Feb. 27, 2006.
Hubner et al., “Enhancement of Monocyte Antimycobacterial Activity by Diethyldithiocarbamate (DTC)” Int. J. Immunopharmac. vol. 13, pp. 1067-1072, 1991.
“Diethyldithiocarbamate”, http:/
citerms.nci.nih.gov/NCIBrowser/ConceptReports.jsp? , pp. 2, Feb. 6, 2006.
“Proventil”, PDR Health, http://www.pdrhealth.com/drug—info/rxdrugprofiles/drugs/pro1360.shtml, pp. 5, Feb. 8, 2006.
“Powered by Dorland's Illustrated Medical Dictionary: E”, MerckSource, http://www.mercksource.com/pp/us/cns/cns—hl—dorlands.jspzQzpgzEzzSzppdocszSzuszSzcommonzSzdorlandszSzdorlandzSzdmd—e—17zPzhtm, pp. 3, Feb. 27, 2006.
F.S. Giorgi et al., “The role of norepinephrine in epilepsy: from the bench to the bedside” Neurosci. Behavioral. Rev.. vol. 28, pp. 507-524, 2004.
K. Bodin et al., “Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4” J. Biol. Chem. vol. 276, pp. 38685-38689, Oct. 19, 2001.
V.S. Kasture et al.,“Anticonvulsant activity ofAlbizzia lebbeckleaves” Indian Journal of Experimental Biology vol. 34, pp. 78-80, Jan. 1996.
V. Fontes et al., “Recurrent Aphthous Stomatitis: Treatment With Colchicine. An Open Trial of 54 Cases”, Ann. Dermatol. Venereol. vol. 129, pp. 1365-1369 , (with abstract), 2002.
P.P. But et al., “Ethnopharmacology of bear gall bladder: I” Journal of Ethnopharmacology vol. 47, pp. 27-31, 1995.
K.G. Rajesh et al., “Hydrophilic Bile Salt Ursodeoxycholic Acid Protects Myocardium Against Reperfusion Injury in a P13K/Akt Dependent Pathway”, Journal of Molecular and Cellular Cardiology, vol. 39, pp. 766-776, 2005.
Cecilia M.P. Rodrigues et al., “Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production”, Molecular Medicine, vol. 4, pp. 165-178, 1998.
“Drug Information: Hydralazine”, Medline Plus, http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682246.html , pp. 3, Apr. 1, 2003.
“Drug Information: Isoxsuprine (System
Baker & Botts L.L.P.
Olson Eric S
LandOfFree
Bile preparations for gastrointestinal disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bile preparations for gastrointestinal disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bile preparations for gastrointestinal disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657632